| Date | Time | Source | Headline | Symbol | Company |
| 11/21/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Vor Biopharma Clinical and Commercial License | LSE:MXCT | Maxcyte Inc |
| 11/14/2019 | 2:01AM | RNS Non-Regulatory | MaxCyte, Inc. Presentation at Jefferies Healthcare Conference | LSE:MXCT | Maxcyte Inc |
| 11/07/2019 | 2:01AM | RNS Non-Regulatory | MaxCyte, Inc. MaxCyte to Present at BIO-Europe 2019 | LSE:MXCT | Maxcyte Inc |
| 11/01/2019 | 9:04AM | UK Regulatory | MaxCyte, Inc. Result of AGM | LSE:MXCT | Maxcyte Inc |
| 10/24/2019 | 7:53AM | Alliance News |  MaxCyte Advances Phase I Clinical Trial Of Cancer Drug MCY-M11 | LSE:MXCT | Maxcyte Inc |
| 10/24/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. MaxCyte Advances Phase I Clinical Trial | LSE:MXCT | Maxcyte Inc |
| 10/23/2019 | 2:01AM | RNS Non-Regulatory | MaxCyte, Inc. Presentations at Cell & Gene Therapy Congress | LSE:MXCT | Maxcyte Inc |
| 10/08/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Notification of AGM and Audit Declaration | LSE:MXCT | Maxcyte Inc |
| 10/07/2019 | 7:23AM | Alliance News | MaxCyte And Editas Ink Five Medicine Licence Deal, EDIT-301 Included | LSE:MXCT | Maxcyte Inc |
| 10/07/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Editas Clinical and Commercial License Agreement | LSE:MXCT | Maxcyte Inc |
| 09/30/2019 | 2:02AM | UK Regulatory | MaxCyte, Inc. Updates on CARMA Platform at Upcoming Meetings | LSE:MXCT | Maxcyte Inc |
| 09/18/2019 | 6:59AM | Alliance News | MaxCyte Interim Rises Revenue But Loss Widens On CARMA Investment | LSE:MXCT | Maxcyte Inc |
| 09/18/2019 | 2:01AM | UK Regulatory | MaxCyte, Inc. Results for the Six Months ended 30 June 2019 | LSE:MXCT | Maxcyte Inc |
| 09/09/2019 | 2:01AM | RNS Non-Regulatory | MaxCyte, Inc. Presentation at ICLE 2019 | LSE:MXCT | Maxcyte Inc |
| 08/14/2019 | 2:02AM | UK Regulatory | MaxCyte, Inc. Notice of Results | LSE:MXCT | Maxcyte Inc |
| 07/17/2019 | 8:43AM | Alliance News | MaxCyte Progresses On MCY-M11 Development As Interim Revenue Rises | LSE:MXCT | Maxcyte Inc |
| 07/17/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Trading Update | LSE:MXCT | Maxcyte Inc |
| 07/11/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. MaxCyte to Host Capital Markets Day Today | LSE:MXCT | Maxcyte Inc |
| 07/05/2019 | 11:42AM | UK Regulatory | MaxCyte, Inc. Second Price Monitoring Extn | LSE:MXCT | Maxcyte Inc |
| 07/05/2019 | 11:36AM | UK Regulatory | MaxCyte, Inc. Price Monitoring Extension | LSE:MXCT | Maxcyte Inc |
| 06/19/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Annual Report | LSE:MXCT | Maxcyte Inc |
| 06/12/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Appointment of Joint Corporate Broker | LSE:MXCT | Maxcyte Inc |
| 05/29/2019 | 2:00AM | RNS Non-Regulatory | MaxCyte, Inc. Save the Date: Capital Markets Day | LSE:MXCT | Maxcyte Inc |
| 05/08/2019 | 11:41AM | UK Regulatory | MaxCyte, Inc. Second Price Monitoring Extn | LSE:MXCT | Maxcyte Inc |
| 05/08/2019 | 11:36AM | UK Regulatory | MaxCyte, Inc. Price Monitoring Extension | LSE:MXCT | Maxcyte Inc |
| 05/08/2019 | 7:11AM | Alliance News | MaxCyte Dosing Second Patients Group In Phase One Cancer Drug Trial | LSE:MXCT | Maxcyte Inc |
| 05/08/2019 | 2:00AM | UK Regulatory | MaxCyte, Inc. Phase I Clinical Trial of MCY-M11 Progressed | LSE:MXCT | Maxcyte Inc |
| 05/01/2019 | 2:01AM | RNS Non-Regulatory | MaxCyte, Inc. ASGCT Presentation on First CARMA Drug Candidate | LSE:MXCT | Maxcyte Inc |
| 04/24/2019 | 6:37AM | Alliance News | MaxCyte Outlook Confident As Loss Narrows In 2018 On Higher Revenue | LSE:MXCT | Maxcyte Inc |
| 04/24/2019 | 2:17AM | UK Regulatory | MaxCyte, Inc. Final Results for Year Ended 31 December 2018 | LSE:MXCT | Maxcyte Inc |